SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-000274
Filing Date
2013-01-08
Accepted
2013-01-07 18:58:23
Documents
20
Period of Report
2013-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K impax_8k-010713.htm 8-K 31197
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 16721
3 slide1.jpg GRAPHIC 89045
4 slide2.jpg GRAPHIC 225249
5 slide3.jpg GRAPHIC 99917
6 slide4.jpg GRAPHIC 83299
7 slide5.jpg GRAPHIC 100463
8 slide6.jpg GRAPHIC 58619
9 slide7.jpg GRAPHIC 67851
10 slide8.jpg GRAPHIC 72006
11 slide9.jpg GRAPHIC 69817
12 slide10.jpg GRAPHIC 84630
13 slide11.jpg GRAPHIC 55891
14 slide12.jpg GRAPHIC 62424
15 slide13.jpg GRAPHIC 86704
16 slide14.jpg GRAPHIC 107334
17 slide15.jpg GRAPHIC 82190
18 slide16.jpg GRAPHIC 102627
19 slide17.jpg GRAPHIC 96727
20 slide18.jpg GRAPHIC 99962
  Complete submission text file 0001437749-13-000274.txt   2317288
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34263 | Film No.: 13516368
SIC: 2834 Pharmaceutical Preparations